However, it is unclear whether changes in duodenal P-gp expression in dogs with CE can be defined as a predisposing factor capable of reducing the effectiveness of the treatment, or if they represent a consequence of previous treatment with immunosuppressive drugs [10,11]. Here, PGP is linked to cholesteryl ester measurement.